1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,120 | 2,140 | 19:07 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.03. | Bioretec Ltd's Board of Directors has decided on a new option program for the CEO | 258 | PR Newswire | Bioretec Ltd Company announcement 21st of March 2025 at 3:00 p.m. EET
TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 21st of March 2025... ► Artikel lesen | |
| 21.03. | Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors | 216 | PR Newswire | Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET
TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 21 March 2025... ► Artikel lesen | |
| 14.03. | Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH) | 268 | PR Newswire | Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET
TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance... ► Artikel lesen | |
| 14.03. | Bioretec Ltd's Annual Report 2024 published | 217 | PR Newswire | Bioretec Ltd Press Release 14 March 2025 at 7:00 p.m. EET
TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Annual Report. The Annual Report... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 07.03. | Mirva Ekman appointed to Bioretec's Management Team as Quality Director | 1 | Cision News | ||
| 28.02. | NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD | 494 | PR Newswire | TAMPERE, Finland, Feb. 28, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 28 February at 12.30 p.m. EET
The shareholders of Bioretec Ltd are hereby invited to the Annual General... ► Artikel lesen | |
| 14.02. | CE Mark Approval for RemeOs Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec | 245 | PR Newswire | TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has achieved a pivotal milestone with the successful completion of its CE mark... ► Artikel lesen | |
| 14.02. | Bioretec Ltd's Financial Statements 2024 published | 355 | PR Newswire | Bioretec Ltd Company announcement 14 February 2025 at 5:00 p.m. EET
TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Financial Statements... ► Artikel lesen | |
| 14.02. | Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025 | 231 | PR Newswire | TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 February 2025 at 8:00 a.m.
This company announcement is a summary of Bioretec Ltd's financial statements... ► Artikel lesen | |
| 31.01. | Inside information: Bioretec Ltd. receives CE mark approval for RemeOs Trauma Screw product portfolio, allowing market launch in Europe | 362 | PR Newswire | TAMPERE, Finland, Jan. 31, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has successfully completed its CE mark approval process and can start commercialization... ► Artikel lesen | |
| 30.01. | Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2025 | 229 | PR Newswire | Bioretec Ltd Company announcement 30 January 2025 at 10.30 a.m EET
TAMPERE, Finland, Jan. 30, 2025 /PRNewswire/ -- The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has... ► Artikel lesen | |
| 16.12.24 | Bioretec Ltd's schedule for financial reporting in 2025 | 5 | Cision News | ||
| 12.12.24 | The Finnish Financial Supervisory Authority has imposed a penalty payment on a member of Bioretec's Board of Directors for late notification of managers' transactions | 6 | Cision News | ||
| 28.11.24 | Bioretec Ltd: 3,000,000 new shares registered with the trade register | 2 | Cision News | ||
| 27.11.24 | Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million | 2 | Cision News | ||
| 27.11.24 | Inside information: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 5 million through a private placement of new shares | - | Cision News | ||
| 22.11.24 | Bioretec signs new distro deal for biodegradable orthopedic implants in the U.S. | 2 | MassDevice | ||
| 22.11.24 | Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs Trauma Screw in the U.S. civilian hospital market | 329 | PR Newswire | Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET
TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic... ► Artikel lesen | |
| 20.11.24 | The commercialization of Bioretec's RemeOs Trauma Screw in the U.S. proceeds with the signing of new logistics agreement | 486 | PR Newswire | Bioretec Ltd Press release 20 November 2024 at 3:30 p.m. EET
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic... ► Artikel lesen | |
| 14.11.24 | Bioretec Ltd's business review January-September 2024: Launch of the RemeOs Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage | 146 | PR Newswire | Bioretec Ltd Company announcement 14 November 2024 at 8:45 a.m.
TAMPERE, Finland, Nov. 14, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-September... ► Artikel lesen |
Seite:
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 52,55 | -4,37 % | Eckert & Ziegler will weiter zulegen - Cyberattacke verzögert Geschäftsbericht | BERLIN (dpa-AFX) - Der Strahlen- und Medizintechnikkonzern Eckert & Ziegler erwartet im neuen Jahr weiteres Wachstum. Der Umsatz soll um etwa acht Prozent auf rund 320 Millionen Euro zulegen, wie das... ► Artikel lesen | |
| DRAEGERWERK | 62,00 | -8,01 % | Drägerwerk: Hauck Aufhäuser Lampe sieht rund 30 Prozent Gewinnpotenzial! | ||
| INTUITIVE SURGICAL | 452,95 | -3,12 % | What the Options Market Tells Us About Intuitive Surgical | ||
| INSULET | 229,50 | -7,53 % | Insulet Stock: Is PODD Outperforming the Healthcare Sector? | ||
| CYTOSORBENTS | 0,914 | -1,40 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights | 2024 marked by strong commercial execution and improved operating leverage
Company continues to expect DrugSorb-ATR regulatory decisions from Health Canada and... ► Artikel lesen | |
| GENEDX | 81,51 | -3,83 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| REVENIO GROUP | 24,500 | -3,39 % | Revenio Group Corporation: U.S. FDA cleared the new iCare MAIA microperimeter | Revenio Group Corporation | Press Release | March 28, 2025 at 09:00:00 EET
Icare, a subsidiary of Revenio Group, has today announced that the U.S. Food and Drug Administration (FDA) has cleared the... ► Artikel lesen | |
| FRESENIUS | 39,710 | +0,53 % | Fresenius SE: Fresenius Medical Care von 32,2 % auf 25 Prozent zu verringern | Aktie im Fokus, die Aktuelle Analyse am 27.03.2025 | ||
| SIEMENS HEALTHINEERS | 46,520 | -7,15 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum zweiten Quartal auf "Buy" mit einem Kursziel von 65 Euro belassen. Die Geschäfte in... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,640 | +2,35 % | Fresenius Medical Care Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| GERRESHEIMER | 64,35 | -5,23 % | Aurubis, Evonik, Gerresheimer, Nagarro, SMA Solar, TUI u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 51,80 | -6,75 % | Dividendenbekanntmachungen (27.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC GB00BF8Q6K64 0,073 GBP 0,0875 EUR AFRICA OIL CORP CA00829Q1019 0,0371 USD 0,0345 EUR AGL ENERGY LIMITED AU000000AGL7 0... ► Artikel lesen | |
| UNITEDHEALTH | 492,00 | +2,05 % | FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage | ||
| RXSIGHT | 15,860 | -39,23 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| ESSILORLUXOTTICA | 249,00 | -6,32 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für EssilorLuxottica vor Quartalszahlen auf "Outperform" mit einem Kursziel von 310 Euro belassen. Im Gegensatz zum unter Druck... ► Artikel lesen |
BIORETEC OY gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,020 (-0,88 %) liegt der Kurs bei 2,240 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.
